Similar Posts
The Week Ahead – The calm before the storm – Orbex Forex Trading Blog
BySilas WThe Week Ahead – The calm before the storm – Orbex Forex Trading Blog XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX” width=”0″ style=”display:none;visibility:hidden”> Source link
Calling the Rally From the Extreme Zone – Forex Market Analysis – ForexCycle.com
BySilas WHello fellow traders. In this technical article we’re going to take a look at the Elliott Wave charts charts of CADJPY Forex pair published in members area of the website. As our members know CADJPY is bullish against the 105.166 pivot and we prefer the long side. Recently the pair made a clear three-wave correction….
Gold – 30.12.2025 – Orbex Forex Trading Blog
BySilas WGold – 30.12.2025 – Orbex Forex Trading Blog XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX” width=”0″ style=”display:none;visibility:hidden”> Source link
USD/JPY Forecast. Fundamental Analysis | 30 May 2025 – ForexNews.PRO
BySilas WUSDJPY: The Japanese yen (JPY) attracted active selling during Thursday’s Asian session in response to news that a US federal court had blocked the entry into force of President Donald Trump’s ‘Liberation Day’ tariffs. This event is boosting investor confidence and triggering a new wave of risk-taking, which in…
Germany mass stabbing: police hunt suspect after three killed at festival in Solingen
BySilas WPolice in Germany are searching for an unknown suspect behind a mass stabbing at a festival on Friday night that killed three and injured eight, five of them seriously. The knife attack took place as thousands of people gathered at the central square in the city of Solingen in the country’s west during celebrations to…
Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision
BySilas WWARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) — Ryan Saadi, MD, MPH, Founder and CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company, reaffirms his commitment to preserving equity for shareholders. Amid ongoing discussions about financing approaches in the biotech sector, Dr. Saadi emphasizes his distinct strategy, which prioritizes…

